Fig. 2

Patients with higher BASP1 expression had shorter overall survival time. a Immunohistochemistry assay showing BASP1 levels in tissues of patients who have died in the follow-up time and the tissues of patients who survived during the follow-up time. BASP1 staining of cervical cancer tissue from survival patients (left), BASP1 staining of cervical cancer tissue from died patients (right) (×100 and ×200, respectively). Statistical analysis of the number of patients with high BASP1 expression and low BASP1 expression in patients who have died and patients who survived, respectively; p = 0.0017. b Kaplan–Meier survival curve and log-rank test for patients with cervical cancer classified as showing either high or low BASP1 expression; p = 0.001